nach oben

Journal of Neurology

Erschienen in:

18.06.2023 | Original Communication

Brain FDG-PET correlates of saccadic disorders in early PSP

verfasst von: G. Pin, J. Labouré, E. Guedj, O. Felician, S. Grimaldi, J. P. Azulay, M. Ceccaldi, L. Koric

Erschienen in: Journal of Neurology | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

New diagnostic criteria of Progressive Supranuclear Palsy (PSP) have highlighted the interest of Eye Movement Records (EMR) at the early stage of the disease.

Objectives

To investigate the metabolic brain correlates of ocular motor dysfunction using [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in early PSP.

Methods

Retrospective observational descriptive study on longitudinal data with patients who underwent EMR and FDG-PET at the stage of suggestive and possible PSP according to Movement Disorders Society criteria. Longitudinal follow-up enables to confirm diagnosis of probable PSP. Using the Statistical Parametric Mapping software, we performed whole-brain voxel-based correlations between oculomotor variables and FDG-PET metabolism.

Results

Thirty-seven patients with early PSP who fulfilled criteria of probable PSP during the follow-up were included. Decrease in the gain of vertical saccades correlated with reduced metabolism in Superior Colliculi (SC). We also found a positive correlation between mean velocity of horizontal saccades and SC metabolism as well as dorsal nuclei in the pons. Finally, increase in horizontal saccades latencies correlated with decrease of posterior parietal metabolism.

Conclusions

These findings suggest the early involvement of SC in saccadic dysfunction in the course of PSP.

Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop*. Neurology 47:1–9. https://doi.org/10.1212/WNL.47.1.1CrossRefPubMed

Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy. Nuchal dystonia and dementia. Arch Neurol 10:333–359. https://doi.org/10.1001/archneur.1964.00460160003001CrossRefPubMed

Respondek G, Kurz C, Arzberger T et al (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord 32:995–1005. https://doi.org/10.1002/mds.27034CrossRefPubMedPubMedCentral

Respondek G, Stamelou M, Kurz C et al (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 29:1758–1766. https://doi.org/10.1002/mds.26054CrossRefPubMed

Marx S, Respondek G, Stamelou M et al (2012) Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson’s disease. Front Behav Neurosci. https://doi.org/10.3389/fnbeh.2012.00088CrossRefPubMedPubMedCentral

Shaikh AG, Factor SA, Juncos JL (2017) Saccades in progressive supranuclear palsy-maladapted, irregular, curved, and slow. Mov Disord Clin Pract 4:671–681. https://doi.org/10.1002/mdc3.12491CrossRefPubMedPubMedCentral

Rivaud-Pechoux S, Vidailhet M, Gallouedec G et al (2000) Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology 54:1029–1032. https://doi.org/10.1212/WNL.54.5.1029CrossRefPubMed

Höglinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria: MDS Clinical Diagnostic Criteria for PSP. Mov Disord 32:853–864. https://doi.org/10.1002/mds.26987CrossRefPubMedPubMedCentral

Garbutt S (2012) Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and alzheimer disease. Arch Neurol 69:509. https://doi.org/10.1001/archneurol.2011.1021CrossRefPubMedPubMedCentral

10.

Groschel K, Kastrup A, Litvan I et al (2006) Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology 66:949–950. https://doi.org/10.1212/01.wnl.0000203342.77115.bfCrossRefPubMed

11.

Amtage F, Maurer C, Hellwig S et al (2014) Functional correlates of vertical gaze palsy and other ocular motor deficits in PSP: an FDG-PET study. Parkinsonism Relat Disord 20:898–906. https://doi.org/10.1016/j.parkreldis.2014.05.013CrossRefPubMed

12.

Verger A, Grimaldi S, Ribeiro M et al (2021) Single photon emission computed tomography/positron emission tomography molecular imaging for parkinsonism: a fast-developing field. Ann Neurol 90:711–719. https://doi.org/10.1002/ana.26187CrossRefPubMedPubMedCentral

13.

Grimm M-J, Respondek G, Stamelou M et al (2019) How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Mov Disord 34:1228–1232. https://doi.org/10.1002/mds.27666CrossRefPubMedPubMedCentral

14.

Buch KA, Bouffard MA, Kardon RH et al (2022) Clinical correlation between vertical gaze palsy and midbrain volume in progressive supranuclear palsy. J Neuroophthalmol 42:246–250. https://doi.org/10.1097/WNO.0000000000001393CrossRefPubMed

15.

Jaillard A, Petyt G, Morelle M (2016) [18F]-Fdg pet identified superior colliculi hypometabolism in progressive supranuclear palsy. J Alzheimers Dis Parkinsonism. https://doi.org/10.4172/2161-0460.1000278CrossRef

16.

Bhidayasiri R, Riley DE, Somers JT et al (2001) Pathophysiology of slow vertical saccades in progressive supranuclear palsy. Neurology 57:2070–2077. https://doi.org/10.1212/wnl.57.11.2070CrossRefPubMed

17.

Soetedjo R, Kaneko CRS, Fuchs AF (2002) Evidence that the superior colliculus participates in the feedback control of saccadic eye movements. J Neurophysiol 87:679–695. https://doi.org/10.1152/jn.00886.2000CrossRefPubMed

18.

Hanes DP, Smith MK, Optican LM et al (2005) Recovery of saccadic dysmetria following localized lesions in monkey superior colliculus. Exp Brain Res 160:312–325. https://doi.org/10.1007/s00221-004-2013-zCrossRefPubMed

19.

Terao Y, Fukuda H, Ugawa Y et al (2013) New perspectives on the pathophysiology of Parkinson’s disease as assessed by saccade performance: a clinical review. Clin Neurophysiol 124:1491–1506. https://doi.org/10.1016/j.clinph.2013.01.021CrossRefPubMed

20.

Blekher T, Weaver M, Rupp J et al (2009) Multiple step pattern as a biomarker in Parkinson disease. Parkinsonism Relat Disord 15:506–510. https://doi.org/10.1016/j.parkreldis.2009.01.002CrossRefPubMedPubMedCentral

21.

Horn AKE (2006) The reticular formation. Prog Brain Res 151:127–155. https://doi.org/10.1016/S0079-6123(05)51005-7CrossRefPubMed

22.

Büttner-Ennever JA, Horn AK, Henn V et al (1999) Projections from the superior colliculus motor map to omnipause neurons in monkey. J Comp Neurol 413:55–67. https://doi.org/10.1002/(sici)1096-9861(19991011)413:1%3c55::aid-cne3%3e3.0.co;2-kCrossRefPubMed

23.

Stanton GB, Goldberg ME, Bruce CJ (1988) Frontal eye field efferents in the macaque monkey: II. Topography of terminal fields in midbrain and pons. J Comp Neurol 271:493–506. https://doi.org/10.1002/cne.902710403CrossRefPubMed

24.

Shinoda Y, Sugiuchi Y, Takahashi M et al (2011) Neural substrate for suppression of omnipause neurons at the onset of saccades. Ann N Y Acad Sci 1233:100–106. https://doi.org/10.1111/j.1749-6632.2011.06171.xCrossRefPubMed

25.

Sparks D, Rohrer WH, Zhang Y (2000) The role of the superior colliculus in saccade initiation: a study of express saccades and the gap effect. Vis Res 40:2763–2777. https://doi.org/10.1016/s0042-6989(00)00133-4CrossRefPubMed

26.

Bisley JW, Goldberg ME (2010) Attention, intention, and priority in the parietal lobe. Annu Rev Neurosci 33:1–21. https://doi.org/10.1146/annurev-neuro-060909-152823CrossRefPubMedPubMedCentral

27.

Pierrot-Deseilligny C, Rosa A, Masmoudi K et al (1991) Saccade deficits after a unilateral lesion affecting the superior colliculus. J Neurol Neurosurg Psychiatry 54:1106–1109. https://doi.org/10.1136/jnnp.54.12.1106CrossRefPubMedPubMedCentral

28.

Ghika J, Tennis M, Growdon J et al (1995) Environment-driven responses in progressive supranuclear palsy. J Neurol Sci 130:104–111. https://doi.org/10.1016/0022-510X(95)00015-TCrossRefPubMed

29.

Shires J, Joshi S, Basso MA (2010) Shedding new light on the role of the basal ganglia-superior colliculus pathway in eye movements. Curr Opin Neurobiol 20:717–725. https://doi.org/10.1016/j.conb.2010.08.008CrossRefPubMedPubMedCentral

30.

Jamadar SD, Fielding J, Egan GF (2013) Quantitative meta-analysis of fMRI and PET studies reveals consistent activation in fronto-striatal-parietal regions and cerebellum during antisaccades and prosaccades. Front Psychol. https://doi.org/10.3389/fpsyg.2013.00749CrossRefPubMedPubMedCentral

31.

Kang SS, Dionisio DP, Sponheim SR (2011) Abnormal mechanisms of antisaccade generation in schizophrenia patients and unaffected biological relatives of schizophrenia patients. Psychophysiology 48:350–361. https://doi.org/10.1111/j.1469-8986.2010.01074.xCrossRefPubMedPubMedCentral

Titel: Brain FDG-PET correlates of saccadic disorders in early PSP
verfasst von: G. Pin
J. Labouré
E. Guedj
O. Felician
S. Grimaldi
J. P. Azulay
M. Ceccaldi
L. Koric
Publikationsdatum: 18.06.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 10/2023
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-023-11824-w

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2023

An update on optic neuritis

Sutton’s law applies to functional neurology

Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapies

Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

Combined genotype of HCRTR2 and CLOCK variants in a large family of cluster headache with familial periodicity phenotype